Who
Catherine J. Mackey
Director
Company insider
Files Form 4 as: Director, IDEAYA Biosciences; Director, Voyager Therapeutics; Director, Avid Bioservices; Director, Trillium Therapeutics; Director, Gw Pharmaceuticals; Director, Poseida Therapeutics; Director, Sequenom.
In numbers
- Trades disclosed
- 66
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $37K
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 17 Jun 2015
- Last trade
- 16 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservicesoption or derivative | SEC FORM 4 Code D | —32,100 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservicesoption or derivative | SEC FORM 4 Code D | —19,675 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservicesoption or derivative | SEC FORM 4 Code D | —10,030 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservicesoption or derivative | SEC FORM 4 Code D | —8,147 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservices | SEC FORM 4 Code D | —43,379 | filing |
| 14 Dec 2024filed 17 Dec 2024 | Avid Bioservicesoption or derivative | SEC FORM 4 Code M | —26,756 at $0.00 | filing |
| 14 Dec 2024filed 17 Dec 2024 | Avid Bioservicesoption or derivative | SEC FORM 4 Code A | —8,147 at $0.00 | filing |
| 14 Dec 2024filed 17 Dec 2024 | Avid Bioservices | SEC FORM 4 Code M | —26,756 | filing |
| 5 Jun 2024filed 7 Jun 2024 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 31 May 2024filed 31 May 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 14 Dec 2023filed 18 Dec 2023 | Avid Bioservicesoption or derivative | SEC FORM 4 Code M | —9,612 at $0.00 | filing |
| 14 Dec 2023filed 18 Dec 2023 | Avid Bioservicesoption or derivative | SEC FORM 4 Code A | —26,756 at $0.00 | filing |
| 14 Dec 2023filed 18 Dec 2023 | Avid Bioservices | SEC FORM 4 Code M | —9,612 | filing |
| 7 Jun 2023filed 9 Jun 2023 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.